Advertisement
Screener

UPSTREAM BIO, INC. (UPB) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

UPSTREAM BIO, INC. Cash Flow Breakdown

Cash flow breakdown shows where UPSTREAM BIO, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $133.28M went out.
  • Fiscal year ended 2025-12-31: from investing, $93.48M went out.
  • Fiscal year ended 2025-12-31: from financing, $2.44M came in.
  • Fiscal year ended 2025-12-31: change in cash, $224.31M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$133.28M-$93.48M$2.28M-$224.31M
2024-12-31-$59.17M-$59.48M$159.00K$418.75M*$300.25M
2023-12-31-$37.93M-$82.84M$118.00K$129.43M*$8.78M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$35.62M*$15.76M*$2.53M*
2026-03-31-$47.85M$42.40M$598.00K-$4.85M
2025-12-31-$30.63M*$58.94M*$907.00K*
2025-09-30-$22.24M*$48.19M*$760.00K*
2025-06-30-$39.24M*$12.77M*$612.00K*
2025-03-31-$41.16M-$213.38M$0.00-$254.58M
2024-12-31-$19.61M*$41.91M*$28.00K*$270.62M*
2024-09-30-$13.96M*$1.41M*$19.00K*-$1.66M*
2024-06-30-$8.04M*-$116.65M*$100.00K*$140.42M*
2024-03-31-$17.56M$13.85M$12.00K$9.38M*$5.68M
2023-12-31-$16.11M*-$5.24M*$0.00*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Perspective Therapeutics, Inc. (CATX)United States$0.284B-3.34
Sagimet Biosciences Inc. (SGMT)United States$0.279B
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
STANDARD BIOTOOLS INC. (LAB)United States$0.297B3.80
Mereo BioPharma Group plc (MREO)$0.269B-9.41
Greenwich LifeSciences, Inc. (GLSI)United States$0.267B-15.02
Vanda Pharmaceuticals Inc. (VNDA)United States$0.302B-1.35
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58